PharmacoEconomics · 2015 · 15 citations · 44 references
PharmacyCardiologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisPreventive CardiologyAtrial FibrillationCost-effectiveness ComparisonEconomic EvaluationPatient AdherenceStrokeThromboembolism PreventionCardioembolic Stroke PreventionEconomic Evaluation AppraisalEconomic Performance EvaluationHealth Economic ReviewPost-stroke AnticoagulationPrimary Stroke PreventionRecurrent Stroke PreventionTreatment Guideline Adherence
44
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · EP Europace · 2012 · 3.8K citations · Full text